Phase 3 Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The participant must be a child or teenager between 2 and 17 years old at the time of joining the trial
- The participant must have been diagnosed with Behçet's disease (a condition that causes recurring sores and inflammation in the body) using standard international diagnostic criteria
- The participant must have had mouth sores (ulcers) at least 3 times in the 12 months before their first screening appointment
- The participant must have at least 2 mouth ulcers present at both their screening appointment and on the first day of the trial
- The participant must have already tried at least one non-biologic treatment for Behçet's disease, such as steroid creams or other medicines taken by mouth or otherwise
Who may not be able to join:
- People whose Behçet's disease is currently causing serious problems in major organs, such as the lungs, blood vessels, digestive system, brain, or eyes requiring strong immune-suppressing medicines — however, if these problems happened more than 1 year ago and are no longer active, joining may still be possible (confirm with trial site)
- People with mild eye-related symptoms from Behçet's disease that do not need strong immune-suppressing medicines may still be allowed to join (confirm with trial site)
- People who have joint or skin symptoms related to Behçet's disease are still allowed to join
- People who have previously been treated with biologic medicines (a specific type of advanced therapy) specifically for Behçet's disease mouth ulcers — however, if biologic medicines were used for a different reason or a different symptom of Behçet's disease, joining may still be possible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: MD, Amgen
Phone: 866-572-6436
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Area Under the Curve for the Number of Oral Ulcers from Week 0 Through Week 12 (AUCw0-12)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.